James R. Major, D.Phil., an Associate of law firm Norris McLaughlin, P.A., will present the webinar, “Patents and Tribal Sovereign Immunity.” Hosted by the American Intellectual Property Law Association, the presentation will discuss the ongoing legal battle involving Allergan’s patents covering the blockbuster dry-eye medication RESTASIS®. In 2017, the patents were purportedly—and controversially—assigned to the St. Regis Mohawk Tribe of Native Americans who asserted tribal sovereign immunity in a challenge to the patents in the United States Patent and Trademark Office. Discussion topics will include the history of sovereign immunity, how it applies to Native American tribes and the associated legal issues, and how the Supreme Court may view the issues going forward.
The webinar is to be held 12:30 p.m. – 2:00 p.m. on Wednesday, January 23, on www.aipla.org, and will cost $95 for AIPLA members and $195 for non-members. To learn more about membership, e-mail AIPLA Member Services at firstname.lastname@example.org. For more information and to register, click here.
Major received his J.D., magna cum laude, in 2011 from New York Law School, where he was on the Dean’s List, and was a candidate for the Trustees’ Prize for the Highest Average in the Evening Division. He was also Staff Editor of the New York Law School Law Review, a John Marshall Harlan Scholar, and a member of the Institute for Information Law and Policy. He received a Doctorate of Philosophy from the University of Oxford in 2003 and his B.A. in Natural Sciences from the University of Cambridge in 1996.
Major dedicates his practice to U.S. and foreign patent and trademark matters. His doctorate in immunology and virology, as well as over ten years’ legal experience, enables him to understand the patentability of new technologies, as well as the science and data required to secure and expand patent protection in light of new statutory subject matter requirements. He has significant patent prosecution experience relating to small molecules, nucleic acids, proteins, antibodies, chemical processes, formulations, industrial processes, and methods of treatment. He is highly experienced in rendering patentability, landscape, freedom-to-operate, and invalidity opinions particularly in the field of biologics. James can assist players in the emerging cannabis industry in the evaluation and securing of patents. He also has patent and trademark litigation experience.